The Australian Alzheimer’s Research Foundation provides significant funding to a team of researchers. We are dedicated to ensuring research continues on an international level by supporting a new generation of Alzheimer’s researchers.
Our central research team includes:
dIRECTOR OF RESEARCH
Prof Ralph Martins AO
Chair of Alzheimer’s and Ageing at Edith Cowan University
Professor Ralph Martins’ research is conducted under the auspices of Australian Alzheimer’s Research Foundation and the Centre of Excellence for Alzheimer’s Disease Research and Care. Click here to read more
CHIEF EXECUTIVE OFFICER
Ms Liza Dunne BBus, GAICD, GradDipFinance
Liza is an experienced CEO who is passionate about medical research that improve lives and outcomes for patient. Liza has built teams with a positive culture based on respect, equality, professionalism, a common purpose and close customer relationships. Liza has strong business and finance acumen, leadership skills and a solid understanding of the medical research environment and the conduct of clinical trials.
Prior to the role of CEO of the Australian Alzheimer’s research Foundation, Liza was CEO of OncoRes Medical Pty developing an imaging diagnostic tool for use by breast cancer surgeons. Prior to this, Liza was Managing Director at Resonance Health Ltd, an ASX listed medical device company providing quantitative medical imaging solutions to hospitals and patients around the globe utilising technology developed at the University of Western Australia.
DIRECTOR OF MEDICINE
Assoc. Prof. Roger Clarnette MBBS, FRACP, PhD
Medical Director, Clinical Trials Division
Dr Clarnette is a Consultant Physician in Geriatric Medicine at Fremantle hospital and directs the Memory Evaluation Unit at the Fremantle hospital which provides comprehensive neuro-psychological evaluation for patients with cognitive and behavioural deficits.
Dr Clarnette is the Principal Investigator for the Clinical Trials Unit at the Australian Alzheimer’s Research Foundation, where a variety of drugs are trialled for potential use in people with the early signs of Alzheimer’s disease.
Dr Hamid Sohrabi
Assoc Prof Simon Laws
Dr Stephanie Rainey-Smith
Dr Belinda Brown